Citation Impact

Citing Papers

Pharmacologic Targeting of Hypoxia-Inducible Factors
2019 StandoutNobel
Global estimates of the need for rehabilitation based on the Global Burden of Disease study 2019: a systematic analysis for the Global Burden of Disease Study 2019
2020 Standout
Venous Thromboembolism and Mortality Associated With Recombinant Erythropoietin and Darbepoetin Administration for the Treatment of Cancer-Associated Anemia
2008
SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
2018 Standout
Normalization of Hemoglobin Level in Patients with Chronic Kidney Disease and Anemia
2006 Standout
Modification of cardiovascular risk in hemodialysis patients: An evidence‐based review
2007
Acute Kidney Injury and Chronic Kidney Disease as Interconnected Syndromes
2014 Standout
Schizophrenia
2009 Standout
Effects of sodium-glucose cotransporter-2 inhibitors on cardiovascular events, death, and major safety outcomes in adults with type 2 diabetes: a systematic review and meta-analysis
2016
Lung Cancer
2008 Standout
Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency
2009 Standout
Systematic Review and Meta-analysis of Exercise Tolerance and Physical Functioning in Dialysis Patients Treated With Erythropoiesis-Stimulating Agents
2010
A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease
2009 Standout
Mortality and target haemoglobin concentrations in anaemic patients with chronic kidney disease treated with erythropoietin: a meta-analysis
2007
Anemia, chronic renal disease and congestive heart failure—the cardio renal anemia syndrome: the need for cooperation between cardiologists and nephrologists
2006
What Makes Clinical Research Ethical?
2000 Standout
Clinical practice guidelines for anemia in chronic kidney disease: problems and solutions. A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)
2008
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
2008 Standout
Associations between Changes in Hemoglobin and Administered Erythropoiesis-Stimulating Agent and Survival in Hemodialysis Patients
2006
Chronic kidney disease
2011 Standout
Prenatal Nutritional Deficiency and Risk of Adult Schizophrenia
2008
Effects of SGLT-2 inhibitors on mortality and cardiovascular events: a comprehensive meta-analysis of randomized controlled trials
2016
A Conserved Mechanism for Sulfonucleotide Reduction
2005 StandoutNobel
Critical appraisal of randomized controlled trials of anemia correction in patients with renal failure
2010
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
2017 Standout
Pharmacodynamics, Efficacy and Safety of Sodium–Glucose Co-Transporter Type 2 (SGLT2) Inhibitors for the Treatment of Type 2 Diabetes Mellitus
2014
Cardiorenal Syndrome
2008 Standout
Type 2 diabetes
2017 Standout
Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention
2013 Standout
Canagliflozin, a sodium glucose co-transporter 2 inhibitor, improves model-based indices of beta cell function in patients with type 2 diabetes
2014
Prevention of Venous Thromboembolism
2004 Standout
Benefits and Harms of Sodium-Glucose Co-Transporter 2 Inhibitors in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis
2016
Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO)
2011
The role of the kidneys in glucose homeostasis in type 2 diabetes: Clinical implications and therapeutic significance through sodium glucose co-transporter 2 inhibitors
2014
Understanding the Intersections between Metabolism and Cancer Biology
2017 Standout
Correction of Anemia with Epoetin Alfa in Chronic Kidney Disease
2006 Standout
Effects of Canagliflozin on Fracture Risk in Patients With Type 2 Diabetes Mellitus
2015
Effect of Early Correction of Anemia on the Progression of CKD
2006
Outcomes of Patients With Severe Chronic Lung Disease Who Are Undergoing Transcatheter Aortic Valve Replacement
2015
Chronic Kidney Disease
2016 Standout
Anemia of Chronic Disease
2005 Standout
Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy
2012 StandoutNobel
Landscape perspectives on agricultural intensification and biodiversity – ecosystem service management
2005 Standout
Enhancement of flame development by microwave-assisted spark ignition in constant volume combustion chamber
2013
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure
2017 Standout
Bioorganometallic Chemistry of Ferrocene
2004 Standout
Genital mycotic infections with canagliflozin, a sodium glucose co-transporter 2 inhibitor, in patients with type 2 diabetes mellitus: a pooled analysis of clinical studies
2014
Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes
2014 Standout
Evaluation and Management of Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2012 Clinical Practice Guideline
2013 Standout
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
A comprehensive review of ZnO materials and devices
2005 Standout
Plasma assisted combustion: Dynamics and chemistry
2015 Standout
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America
2017 Standout
Alkaline Phosphatase Revisited:  Hydrolysis of Alkyl Phosphates
2002
Research Involving Human Subjects
1978 Science
Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
2018 Standout
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Peptide mapping by limited proteolysis in sodium dodecyl sulfate and analysis by gel electrophoresis.
1977 Standout
Measurements of combustion properties in a microwave enhanced flame
2009
Correlation of thermodynamic and kinetic properties of the phosphoryl-enzyme formed with alkaline phosphatase
1980
Efficacy and safety of sodium glucose co‐transport‐2 inhibitors in type 2 diabetes: a meta‐analysis of randomized clinical trials
2013
Phosphoproteins
1974
The role of erythropoietin and its receptor in growth, survival and therapeutic response of human tumor cells
2010
Cardiovascular Safety, Long‐Term Noncardiovascular Safety, and Efficacy of Sodium–Glucose Cotransporter 2 Inhibitors in Patients With Type 2 Diabetes Mellitus: A Systemic Review and Meta‐Analysis With Trial Sequential Analysis
2018
Meta-analysis: Erythropoiesis-Stimulating Agents in Patients With Chronic Kidney Disease
2010
Haemoglobin and haematocrit targets for the anaemia of chronic kidney disease
2006
Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes
2020 Standout
A Study of Plasma-Stabilized Diffusion Flames at Elevated Ambient Temperatures
2008
Sodium Glucose Cotransporter 2 Inhibitors in the Treatment of Diabetes Mellitus
2016
Solid‐Phase Sequence Analysis of Polypeptides Eluted from Polyacrylamide Gels
1982 StandoutNobel
Hydrolysis of a stable oxygen ester of phosphorothioic acid by alkaline phosphatase
1972
Purification of the Sodium- and Potassium-dependent Adenosine Triphosphatase from Canine Renal Medulla
1971
The purified product of the transforming gene of avian sarcoma virus phosphorylates tyrosine.
1980 StandoutNobel
Randomized, Double-Blind, Placebo-Controlled Trial of Erythropoietin in Non–Small-Cell Lung Cancer With Disease-Related Anemia
2007
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
Somatic inactivation of the PHD2 prolyl hydroxylase causes polycythemia and congestive heart failure
2007 StandoutNobel
Canagliflozin Provides Durable Glycemic Improvements and Body Weight Reduction Over 104 Weeks Versus Glimepiride in Patients With Type 2 Diabetes on Metformin: A Randomized, Double-Blind, Phase 3 Study
2014
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Efficacy and safety of canagliflozin over 52 weeks in patients with type 2 diabetes on background metformin and pioglitazone
2014
Assessment of the rate of bound substrate interconversion and of ATP acceleration of product release during catalysis by mitochondrial adenosine triphosphatase.
1984 StandoutNobel
Adenosine 5′-0(3-thiotriphosphate) in the control of phosphorytase activity
1974 StandoutNobel
Effect of canagliflozin on serum electrolytes in patients with type 2 diabetes in relation to estimated glomerular filtration rate (eGFR)
2014
Urinary tract and genital infections in patients with type 2 diabetes treated with sodium‐glucose co‐transporter 2 inhibitors: A meta‐analysis of randomized controlled trials
2016
Safety and Efficacy of Darbepoetin Alfa in Previously Untreated Extensive-Stage Small-Cell Lung Cancer Treated With Platinum Plus Etoposide
2008
Presteady State Kinetics of Phosphorothioate Hydrolysis by Alkaline Phosphatase
1972
HIGHER-ORDER PREDATORS AND THE REGULATION OF INSECT HERBIVORE POPULATIONS
1998
Impact of Diabetes Care by Pharmacists as Part of Health Care Team in Ambulatory Settings: A Systematic Review and Meta-analysis
2017
Anemia in Chronic Heart Failure
2006
Measurements of Hydrocarbon Flame Speed Enhancement in High-Q Microwave Cavity
2006
Pseudopotentials and Total Energy Calculations
1982
The effects of canagliflozin, a sodium glucose co-transporter 2 inhibitor, on mineral metabolism and bone in patients with type 2 diabetes mellitus
2016
Treatment of erythropoietin deficiency in mice with systemically administered siRNA
2012 StandoutNobel
Effectiveness of Rehabilitation Interventions to Improve Gait Speed in Children With Cerebral Palsy: Systematic Review and Meta-analysis
2016
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Selective dephosphorylation of proteins containing phosphotyrosine by alkaline phosphatases.
1981 StandoutNobel

Works of Daniel J. Sullivan being referenced

Perinatal Brain Iron Deficiency Increases the Vulnerability of Rat Hippocampus to Hypoxic Ischemic Insult
1999
Double-Blind Comparison of Full and Partial Anemia Correction in Incident Hemodialysis Patients without Symptomatic Heart Disease
2005
Efficacy and Safety of Canagliflozin Treatment in Older Subjects With Type 2 Diabetes Mellitus: A Randomized Trial
2013
A Review of Advances in Collaborative Pharmacy Practice to Improve Adherence to Standards of Care in Diabetes Management
2014
Effects of canagliflozin on body weight and relationship to HbA1c and blood pressure changes in patients with type 2 diabetes
2015
Muscle force production and functional performance in spastic cerebral palsy: Relationship of cocontraction
2000
Determinants of pulmonary function in patients undergoing coronary bypass operations
1990
Evaluation of Bone Mineral Density and Bone Biomarkers in Patients With Type 2 Diabetes Treated With Canagliflozin
2015
Long‐term efficacy and safety of canagliflozin over 104 weeks in patients aged 55–80 years with type 2 diabetes
2014
Efficacy and Safety Analysis of Epoetin Alfa in Patients With Small-Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Trial
2005
Insect Hyperparasitism
1987
Research on Human Subjects
1975
Long-Term Efficacy and Safety of Canagliflozin (CANA) in Older Patients with Type 2 Diabetes Mellitus (T2DM) Over 104 Weeks
2014
Microwave-assisted Hydrocarbon Flame Speed Enhancement
2005
Mechanistic significance of phosphate labeling of alkaline phosphatase
1969
Numerical Study of the Effect of Microwave Discharge on the Premixed Methane-air Flame
2004
Social currents in weak interactions
1979
Rankless by CCL
2026